29

29 10 11 ( )12

1

49

92

2

3

29

28

4

5

28

6

28

98 8,500 13

1,120 116 9,620

226 8,620 109 9,000

116 9,620

30

15

12

7

2025

15

2025

26

2,500

28

5,000

12

8

29

27

30

10

31

29

9

COI COI

COI

30

50

2025

2025

45 360

720

10

31

36

30

31

11 12

11 12

12

11

20

11

14

31

14

12

10

20 30

2020

28 191

483

2

68 21

17 28

13

g/dL 1A 1A

2C 2D

5 / L 2D

2 /mL 2D

PT 2.0 30 APTT

2 25 100mg/dL

150

2B

10 15mL/kg

2.5

14

3.0g/dL 2.5g/dL

1B 2D 1B

2B 2D

2D

1B

200 400mL

1A

2C

15

MTP Massive Transfusion Protocol

16

AABB

AABB Trauma hemostasis&Oxygenation Research:

THOR AABB/THOR Joint Working Group

Hemorrhagic Shock Resuscitation Workshop

preventable death

COI

30

17

100

FFP 1.5

FFP

civilian

FFP FFP

FFP

16 FFP

FFP

30

1:1:1

FFP,

FFP

FFP

FFP

FFP FFP

FFP FFP

FFP

survivorship bias

survivorship bias

survivorship bias Plasma: RCC

FFP

cutoff 1 1 30

18

survivorship bias 30

905 25

24

plasma:RBC

platelets:RBC 6

24 FFP 24

FFP

FFP

survivorship bias 24

disadvantage

FFP Thawed plasma

plasma

AB

AB AB low titer B A

TRALI

FFP

vWF von Willebrand factor vWF N

FFP

FFP

19

PROPPR study Plasma:

FFP container

container

FFP

FFP

10

24 30 all-cause mortality

1:1:1

24

thawed plasma

AB AB

A Universal donor

Massive Transfusion Protocols

30

PROPPR study

container

container

15

Massive Transfusion Protocols

15 10

20

AABB

FFP

Massive Transfusion Protocols

post-hock 24

survivorship bias 24

FFP

plasma

Massive

Transfusion Protocols

FFP

Blood Bank

Blood Bank

1-

thawed

plasma

AABB

21

AABBstandards

AABB low titer group O AABB standards

low titer group O A

B 256 O

FFP

400cc

Freeze-dried plasma

Refrigerated Platelets

cold platelets FDA

cold platelets

cold platelets 14

cold platelets

Massive Transfusion Protocols

22

Massive Transfusion Protocols

VII

primary endpoint

Rahe-Meyer Hannover

150

2017

200

feasibility study

ROTEM PCC

prothrombin complex concentrate

RCT

23

plasma

Grade 1B 1C

30

ROTEM

TEG

FFP

AABB

40

FFP

POC device

1 1 1

DIC

PAI-1

MTP MTP MTP

24

MTP

prehospital

Freeze-dried

plasma MTP

MTP

FFP

FFP

25

Massive Transfusion Protocols Damage

Control Resuscitation

Damage Control

Resuscitation Massive Transfusion Protocols

cold platelets

26

cold platelets

FDA

AABB

MTP

FFP

MTP

1B

150 200

1C

Transfusion

125 123 MTP

27

93

ER 4 1

2 25 28

10

108

8,345

O

11.5 1,225

O

MTP

MTP

MTP 10

O MTP

10 n=10

MTP

FFP

FFP MTP

2016 1 106 23

10 n=10

28

MTP 15

FFP 30

15 50 MTP

MTP

MTP

MTP

MTP

FFP

MTP TACO

MTP

MTP O 10

FFP FFP

FFP

FFP

MTP 72

29

AMED

MTP

O

MTP

FFP

30

MTP

31

19

5.5 12.7

21

12

ABO

20

32

O

A4

33

2006

2012 58

2023

Advanced OSCE

Post-Clinical Clerkship OSCE

34

53 73

37 44

39 38

Cell Processing Center

40

90

78

35

93 100

199 164 25

145

616 313 15

240

52

14 31 4

731 HLA 50

FFP

20

28 11 6,000

20

21 13.2 25

9.8

FFP PC 20

FFP

79

36

23

HLA

A&T

78

72

92

12

10

37

IC

IC

38

31 64

31

2019 31 11 14

18

39

10 19

10

40

41